This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignees: Riken Corporation, Yokohama City University. Active years: 2016-2026.
Company Filing History:
2 out of 889 
1 out of 57 
Years Active: 2016-2026
Title: Ko Kikuzato: Innovator in Mitochondrial Research
Introduction
Ko Kikuzato is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of mitochondrial research, particularly through his innovative patents. With a total of 2 patents, Kikuzato's work focuses on developing compounds that have therapeutic effects on various diseases.
Latest Patents
Kikuzato's latest patents include a mitochondrial permeability transition pore (mPTP)-opening inhibitor and an auxin biosynthesis inhibitor. The mPTP-opening inhibitor aims to provide a novel compound with high mPTP-opening inhibitory activity, which can be beneficial in treating various diseases. This invention includes a medicament or pharmaceutical composition comprising a compound represented by a specific formula, along with its stereoisomers, prodrugs, or pharmaceutically acceptable salts. The auxin biosynthesis inhibitor is designed to be superior to L-AOPP, utilizing a compound represented by a general formula to achieve its objectives.
Career Highlights
Throughout his career, Ko Kikuzato has worked with notable organizations such as Riken Corporation and Yokohama City University. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Kikuzato has collaborated with esteemed colleagues, including Tadao Asami and Megumi Narukawa. These partnerships have further enriched his research endeavors and innovations.
Conclusion
Ko Kikuzato's work in mitochondrial research exemplifies the impact of innovative thinking in the field of medicine. His patents reflect a commitment to developing effective therapeutic solutions for complex diseases.